NDLI: Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis

Content Provider	Springer Nature : BioMed Central
Author	Olyaaeemanesh, Alireza Jaafaripooyan, Ebrahim Abdollahiasl, Akbar Davari, Majid Mousavi, Seyyed Meysam Delpasand, Mansoor
Abstract	Background Over the past three decades, allocation of foreign currency subsidies has been the primary strategy of various administrations in Iran to improve access to medicines. This strategy has resulted in several challenges, including stakeholder conflicts of interest. Objective To identify the power, interest, and role of the stakeholders in allocating foreign currency subsidies to medicines in the Iranian health system. Methods In this qualitative study, 39 semi-structured interviews were conducted. Key informants were recruited using a purposive sampling technique. The theoretical framework adopted by Varvasovszky and Brugha was employed. The data were analysed using directed content analysis. Results The foreign currency subsidy for medicines included 21 stakeholders in five main categories: governmental organizations, Iranian Parliament, general population, nongovernmental organizations (NGOs), and the pharmaceutical industry. Stakeholders varied in their level of participation and support in the policy-making process. Among them, the Iranian Government, Planning and Budget Organization, the Ministry of Health and Medical Education (MoHME), and Iran Food and Drug Administration (IFDA) were the most important stakeholders, with highly supportive positions, while domestic drug manufacturers were the strongest opponents of this policy. The Government of Iran is the most powerful institution with regard to the ability to allocate foreign currency subsidies to medicines, followed by the MoHME and the IFDA. Conclusion This study demonstrated that identifying and analysing the stakeholders involved in allocating foreign currency subsidies to medicines can provide valuable information for policy-makers to enable a more comprehensive understanding and better capacity to determine whether or not to eliminate these subsidies. Moreover, decision-making in this process is a long-term issue that requires consensus among all stakeholders. Because of the political and social consequences of eliminating foreign currency subsidies, the necessary political will is not institutionalized. We recommend a step-by-step approach in eliminating foreign currency subsidies if the requirements are met (i.e., those related to the consequences of such interventions). Therefore, revision of the current policy along with these requirements, in addition to financial transparency and enhanced efficiency, will facilitate progress towards achieving the Sustainable Development Goals by improving access to medicines.
Related Links	https://health-policy-systems.biomedcentral.com/counter/pdf/10.1186/s12961-021-00762-6.pdf
Ending Page	17
Page Count	17
Starting Page	1
File Format	HTM / HTML
ISSN	14784505
DOI	10.1186/s12961-021-00762-6
Journal	Health Research Policy and Systems
Issue Number	1
Volume Number	19
Language	English
Publisher	BioMed Central
Publisher Date	2021-12-23
Access Restriction	Open
Subject Keyword	Health Administration R & D Technology Policy Medicine Public Health Health Services Research Health Policy Pharmaceutical subsidy Stakeholder analysis Iran R & D/Technology Policy Medicine/Public Health
Content Type	Text
Resource Type	Article
Subject	Health Policy
Journal Impact Factor	3.6/2023
5-Year Journal Impact Factor	4.3/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis

Sixteen years of eHealth experiences in Iran: a qualitative content analysis of national policies

Priority-setting in health research in Iran: a qualitative study on barriers and facilitators

Policy analysis of self-care program: a qualitative study protocol

Analysis and exploration of infertility policies in Iran: a study protocol

Palliative care stakeholders in Canada

Use of qualitative research in World Health Organisation guidelines: a document analysis

The challenges of implementation of clinical governance in Iran: a meta-synthesis of qualitative studies

Learning by doing in practice: a roundtable discussion about stakeholder engagement in implementation research

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis

Similar Documents

Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis

Sixteen years of eHealth experiences in Iran: a qualitative content analysis of national policies

Priority-setting in health research in Iran: a qualitative study on barriers and facilitators

Policy analysis of self-care program: a qualitative study protocol

Analysis and exploration of infertility policies in Iran: a study protocol

Palliative care stakeholders in Canada

Use of qualitative research in World Health Organisation guidelines: a document analysis

The challenges of implementation of clinical governance in Iran: a meta-synthesis of qualitative studies

Learning by doing in practice: a roundtable discussion about stakeholder engagement in implementation research

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis